A comprehensive view of Laminar Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Executive Perspective: J&J to continue its aggressive medtech M&A strategy after spending US$30.0B in less than two years, says CEO; recent acquisitions include Shockwave Medical, Abiomed, Laminar, and Ambrx, as the company targets long-term growth
Published:
April 17, 2024
by FierceBiotech
|
J&J MedTech completes acquisition of Laminar Inc., a medical device company specializing in left atrial appendage elimination to reduce stroke risk in non-valvular atrial fibrillation patients; deal included an upfront payment of US$400.0M
Published:
November 30, 2023
by Biosense Webster Inc.
|
Ask us about our Health Care Sector market view